Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections are administered once weekly subcutaneously, and proper injection technique directly affects medication absorption and treatment outcomes. Understanding the correct administration method transforms what many patients perceive as an intimidating process into a straightforward routine. PlexusDx compounded semaglutide injections start at $149 per month and come with comprehensive guidance to ensure you inject with confidence.

Preparing Your Semaglutide Injection Site and Supplies

Before administering your weekly semaglutide injection, gather all necessary supplies in a clean, well-lit workspace. You will need the semaglutide pen or vial, an alcohol prep pad, sterile gauze, a sharps disposal container, and any supplies specific to your PlexusDx prescription. Organizing these items beforehand prevents interruptions during injection and reduces anxiety about the process.

Proper storage of semaglutide is essential for maintaining medication potency. Keep your pen or vial in the refrigerator between 36°F and 46°F (2°C to 8°C) until you are ready to use it, and allow it to reach room temperature for 15–30 minutes before injection. Never freeze semaglutide, and always inspect the solution for cloudiness or particles; if either is present, do not use the medication and contact PlexusDx for a replacement.

Select an injection site on your abdomen, thigh, or upper arm—areas with adequate subcutaneous tissue and away from bony prominences or sensitive zones. Rotate your injection site each week to prevent lipodystrophy (uneven fat deposits under the skin), which can affect medication absorption over time. Mark a mental or written note of where you injected so you naturally alternate locations and distribute the medication evenly.

Step-by-Step Semaglutide Injection Technique

Cleanse your chosen injection site thoroughly with an alcohol prep pad using firm, circular motions for at least 30 seconds. Allow the area to air-dry completely for 60 seconds; injecting into wet skin can dilute the medication and cause discomfort. Dry skin also reduces the risk of introducing bacteria into the subcutaneous tissue.

Hold the semaglutide pen or syringe at a 90-degree angle to your skin (straight in, perpendicular to the surface). Pinch a fold of skin and fatty tissue between your thumb and forefinger to create a target zone, then insert the needle firmly but smoothly in one fluid motion. Most patients report that the 28–32 gauge needles used for semaglutide injections cause minimal pain when inserted correctly and quickly.

Once the needle is fully inserted, press the injection button or plunger slowly and steadily to deliver the medication. Rushing the injection can increase pressure and cause tissue trauma, while injecting too slowly may trigger cramping or discomfort. After the dose is fully delivered, wait 3–5 seconds before withdrawing the needle to ensure all medication has been dispersed into the tissue.

Managing Common Injection Site Reactions and Discomfort

Mild redness, swelling, or a small bruise at the injection site is normal and typically resolves within hours to a few days. If you experience persistent redness lasting longer than 48 hours, severe swelling, warmth, or pus, contact your PlexusDx clinical team immediately, as these signs may indicate infection. Most patients find that injection site reactions decrease after the first few weeks as their body adjusts to the medication.

Pain or stinging during injection can often be minimized by ensuring your needle is sharp (never reuse needles), your skin is clean and dry, and the semaglutide solution has warmed to room temperature. If you tend toward needle anxiety, practice slow breathing techniques before and during your injection, or ask a family member to be present for support. PlexusDx provides optional one-on-one injection coaching calls to patients who need additional confidence-building assistance.

Injection site nodules—small, firm bumps under the skin—may develop if you repeatedly inject into the exact same spot. These are benign but uncomfortable and can impair absorption. Rotating injection sites meticulously prevents nodule formation; mark a grid pattern on your abdomen or thigh and move systematically from one location to the next each week.

Optimizing Semaglutide Delivery for Best Results

Consistent injection timing enhances semaglutide's appetite-suppressing and metabolic effects. Choose the same day and time each week—for example, every Monday morning—and set a phone reminder to build the habit into your routine. This consistency allows your body to maintain steady medication levels and provides a predictable schedule for dose adjustments if needed.

Your dose may gradually increase over the first 4–5 weeks as PlexusDx adjusts your therapy based on your response and tolerance. The key principle is: your dose may need to go up, but your price won't—PlexusDx maintains flat monthly pricing regardless of dose level. If you experience inadequate appetite suppression or significant side effects, communicate these outcomes to your PlexusDx clinical team so they can optimize your regimen.

For patients interested in precision personalization, the PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) identifies genetic variants in pathways like GLP1R and GIPR that influence how your body processes semaglutide. Understanding your genetic profile helps your clinician predict dose escalation patterns and potentially switch to alternative compounds like tirzepatide if your genetic makeup suggests a stronger response to other peptide agents.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide while traveling, or does it require special storage?

Semaglutide can travel with you if kept in an insulated cooling case with cold packs, maintaining 36°F–46°F (2°C–8°C). PlexusDx recommends purchasing a portable medication cooler or travel case before your first injection. Once warmed to room temperature, semaglutide remains stable for up to 30 minutes, giving you flexibility to inject at your scheduled time even away from a refrigerator.

How deep should the needle go, and what happens if I inject intramuscularly by accident?

Semaglutide is designed for subcutaneous injection, meaning the needle should penetrate only into the fatty layer beneath the skin, typically ¼ to ½ inch (6–13 mm) deep. If you accidentally inject into muscle (intramuscular), the medication will absorb faster and more erratically, potentially causing stronger side effects or less consistent appetite suppression. Contact your PlexusDx clinician immediately if you suspect an intramuscular injection so they can monitor your response.

Is PlexusDx semaglutide covered by insurance, and what payment options are available?

PlexusDx compounded semaglutide injections start at $149 per month and do not require insurance, though HSA and FSA accounts can be used to pay for your prescription. PlexusDx serves all 50 states with no membership fee, and pricing remains flat regardless of dose adjustments. Payment is simple and transparent—no surprise costs as your therapy progresses.

What should I do if I miss my weekly injection or inject early?

If you miss your injection, take it as soon as you remember unless it is within 2 days of your next scheduled dose—in that case, wait and resume your normal weekly schedule. Missing one dose will not cause harm, but consistency is important for weight loss and metabolic benefits. Inject early only if you wish to shift your injection day permanently; talk to your PlexusDx team if you need to change your weekly schedule.

Can the Precision Peptide Genetic Test predict how I will respond to semaglutide injections?

The PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, and other metabolic pathways that influence your semaglutide response and optimal dose escalation. Patients with specific GLP1R rs6923761 variants may require higher doses for appetite suppression, while those with GIPR rs1800437 variants may benefit from combination therapies like GLP-Squared. Testing costs $99 after your first month and allows PlexusDx clinicians to personalize your regimen based on your peptide genetics.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves